Prosecution Insights
Last updated: May 29, 2026
Application No. 18/777,500

SYSTEM AND METHODS FOR AN ORTHOPEDIC PILLOW THAT REPELS MICROBES AND FUNGI

Non-Final OA §103§112
Filed
Jul 18, 2024
Examiner
KURILLA, ERIC J
Art Unit
3619
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
Imbibe Lifestyles LLC
OA Round
1 (Non-Final)
71%
Grant Probability
Favorable
1-2
OA Rounds
5m
Est. Remaining
98%
With Interview

Examiner Intelligence

Grants 71% — above average
71%
Career Allowance Rate
563 granted / 796 resolved
+18.7% vs TC avg
Strong +28% interview lift
Without
With
+27.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 4m
Avg Prosecution
38 currently pending
Career history
825
Total Applications
across all art units

Statute-Specific Performance

§101
1.0%
-39.0% vs TC avg
§103
69.6%
+29.6% vs TC avg
§102
10.4%
-29.6% vs TC avg
§112
9.5%
-30.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 796 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Invention II (Claims 6-10) in the reply filed on March 24th, 2026 is acknowledged. Claims 1-5 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on March 24th, 2026. Claim Objections Claim 10 objected to because of the following informalities: Please delete the word “indent” in the second line of the claim as it appears to be extraneous. Appropriate correction is required. Claim Rejections - 35 USC § 112 Claims 9 and 10 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 9 and 10 recites the limitation "a foam piece". It is unclear if “a foam piece” is included in “at least one foam piece” recited in parent claim 6, or if “a foam piece” is a separate limitation in addition to “at least one foam piece”. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 6-10 is/are rejected under 35 U.S.C. 103 as being unpatentable over Dixon (US 5,163,194) in view of Manuszak (US 2022/0408945) and Pan (CN 113261830). Regarding Claim 6, Dixon discloses a customized orthopedic pillow comprising: At least one foam piece (4 and 6); wherein the size, shape and density of at least one foam piece is determined by information about the consumer (see Col. 4, Lines 20-38 and Col. 7, Lines 7-26); wherein at least one foam piece is composed of a polyurethane foam (see Col. 4, Lines 20-24). Dixon fails to disclose the polyurethane foam containing copper and further covered with a layer of gel containing silver. Manuszak teaches a polyurethane foam (see para. [0032]) containing copper (see para. [0070]). Dixon and Manuszak are analogous art because they are from the same field of endeavor, i.e. pillows. It would have been obvious to one having ordinary skill in the art at the time the invention was filed to modify the polyurethane foam of Dixon with the copper of Manuszak. The motivation would have been to inhibit moisture and mold growth. Pan further teaches a pillow further covered with a layer (21) of gel containing silver (see “one side of the cotton cloth is provided with nano-silver antibacterial gel” in English translation). Dixon and Pan are analogous art because they are from the same field of endeavor, i.e. pillows. It would have been obvious to one having ordinary skill in the art at the time the invention was filed to modify the pillow of Dixon with the layer of gel containing silver of Pan. The motivation would have been to provide a sweat-absorbing antibacterial layer, thus preventing bacteria from accumulating on the surface that contacts a user’s head. Regarding Claim 7, Dixon discloses wherein the information includes whether the consumer prefers to sleep in a lateral sleeping position, a supine sleeping position, or a mixture of both (see Col.1, Lines 35-45). Regarding Claim 8, Dixon discloses wherein the information is generated from input by the consumer (see Col. 4, Line 62- Col. 5, Line 10). Regarding Claim 9, Dixon discloses wherein a foam piece consists of a sloped section containing an indentation in the center to place a sleeper's neck and a divot to rest the head (see annotated Fig. 1 below). Regarding Claim 10, Dixon discloses wherein a foam piece consists of a curved section to place a sleeper's neck indent and a divot to rest the head (see annotated Fig. 1 below). PNG media_image1.png 410 702 media_image1.png Greyscale Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. See attached PTO-892. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ERIC J KURILLA whose telephone number is (571)270-7294. The examiner can normally be reached Monday-Thursday 7AM-6PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anita Coupe can be reached at 571-270-3614. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ERIC J KURILLA/ Primary Examiner, Art Unit 3619
Read full office action

Prosecution Timeline

Jul 18, 2024
Application Filed
Apr 22, 2026
Non-Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12636209
Bed Base Frame
3y 5m to grant Granted May 26, 2026
Patent 12636981
CHILD SAFETY SEAT
1y 11m to grant Granted May 26, 2026
Patent 12636979
SEATBACK LOCKING DEVICE
1y 8m to grant Granted May 26, 2026
Patent 12611036
STACKABLE LIFT FOR ISCHIAL TUBEROSITY RE-ALIGNMENT OF SACRAL/LUMBAR COMPLEX AND METHOD OF USE
3y 6m to grant Granted Apr 28, 2026
Patent 12611348
A PATIENT TRANSFER DEVICE
2y 6m to grant Granted Apr 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
71%
Grant Probability
98%
With Interview (+27.7%)
2y 4m (~5m remaining)
Median Time to Grant
Low
PTA Risk
Based on 796 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month